Picture of Equillium logo

EQ — Equillium News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Equillium Inc expected to post a loss of 38 cents a share - Earnings Preview

* Equillium Inc  EQ.OQ   EQ.O  is expected to show no change
in
quarterly revenue when it reports  results on November 8
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Equillium Inc is
for a
loss of 38 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Equillium
Inc is
$12​, above​ its last closing price of $1.71. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.41       -0.41      -0.41     Met     1.2
 Mar. 31 2022  -0.37       -0.37      -0.45     Missed  -20.8
 Dec. 31 2021  -0.37       -0.34      -0.36     Missed  -5.3​
 Sep. 30 2021  -0.34       -0.34      -0.35     Missed  -3.4
 ​​Jun.        -0.30       -0.31      -0.31     Met     -1.1
 30 2021                                                
 Mar. 31 2021  -0.33       -0.32      -0.33     Missed  -2.5​
 Dec. 31 2020  -0.37       -0.40      -0.36     Beat    10.4
 Sep. 30 2020  -0.42       -0.40      -0.31     Beat    22
 This summary was machine generated November 4 at 12:46 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Equillium

See all news